Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Nanomedicine: HELP
Twan Lammers
Based on 29 articles published since 2009
(Why 29 articles?)
||||
Expertise Level
The expertise of Twan Lammers ranks in the
  • Top 0.0091%
  • ... of 22,081 published authors worldwide on Nanomedicine
  • ... from 2009 through 2019
  • ... based on contributions to 29 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Lammers, T   ·   Lammers, Twan
Work Locations
Details
Most likely:    RWTH Aachen      
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
2016
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2012
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Pubmed 22829203
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2010
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21143030
2019
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Pubmed 30465669
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
2012
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21907796
Probable:    Universiteit Utrecht      
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands. · Pubmed 19951732
2012
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 21907797
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
2009
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. · Pubmed 19166276
Probable:    Universiteit Twente      
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 29 total) written by Twan Lammers about Nanomedicine:

  • Nanomedicine and macroscale materials in immuno-oncology. 2019
  • Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies. 2018
  • Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. 2017
  • Enhancing Tumor Penetration of Nanomedicines. 2017
  • Tumor-targeted nanomedicines for cancer theranostics. 2017
  • Status and trends in the development of clinical diagnostic agents. 2017
  • Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. 2017
  • Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers. 2017
  • Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond. 2017
  • Polymeric Selectin Ligands Mimicking Complex Carbohydrates: From Selectin Binders to Modifiers of Macrophage Migration. 2017
Show List of Full Article Records
Google Searches

Learn more about Twan Lammers using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
RWTH Aachen
Universiteit Utrecht
Universiteit Twente
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
RWTH Aachen
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
2016
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2012
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Pubmed 22829203
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2010
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21143030
2019
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Pubmed 30465669
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
2012
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21907796
Universiteit Utrecht
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands. · Pubmed 19951732
2012
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 21907797
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
2009
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. · Pubmed 19166276
Universiteit Twente
2018
  • School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · School of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. · Pubmed 30084044
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Chemical Engineering, Delft University of Technology, 2628BL Delft, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands. · Pubmed 27865762
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: · Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom. · Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands. · Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. · Pubmed 27137110
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
2014
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
Miscellaneous institutions in Aachen
2017
  • Institut für Organische Chemie, Johannes Gutenberg-Universität Mainz, Duesbergweg 10-14, 55128, Mainz, Germany. · Medizinische Klinik III, Uniklinikum Aachen, Germany. · Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie, Charité-Universitätsmedizin Berlin, Germany. · Institut für Molekulare Herz-Kreislaufforschung (IMCAR), Uniklinikum Aachen, Germany. · Institut für Experimentelle Molekulare Bildgebung (ExMI), Uniklinikum Aachen, Germany. · Pubmed 28005299
Yearly article counts 11813126231
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.